Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2021. Start Trial.
Date Value
September 30, 2026 -158.54M
June 30, 2026 -156.85M
March 31, 2026 -158.74M
December 31, 2025 -167.10M
September 30, 2025 -115.10M
June 30, 2025 -107.00M
March 31, 2025 -111.41M
December 31, 2024 -130.16M
September 30, 2024 -190.32M
June 30, 2024 -205.20M
Date Value
March 31, 2024 -200.61M
December 31, 2023 -174.14M
September 30, 2023 -163.96M
June 30, 2023 -156.77M
March 31, 2023 -139.00M
December 31, 2022 -147.92M
September 30, 2022 -125.96M
June 30, 2022 -102.50M
March 31, 2022 -84.82M
December 31, 2021 -38.23M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Intellia Therapeutics, Inc. -358.08M
Beam Therapeutics, Inc. -398.24M
Twist Bioscience Corp. -95.96M
Moderna, Inc. -2.044B
Q32 Bio, Inc. -20.07M